Dachaigh › Luchd-obrach › Deciphera Pharmaceuticals, LLC
Deciphera Pharmaceuticals, LLC: Tuarastalan H-1B agus taic bhìosa
Chuir Deciphera Pharmaceuticals, LLC 7 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 7. Tuarastal meadhanach a chaidh a thabhann: $155,000.
A bheil Deciphera Pharmaceuticals, LLC a’ toirt taic do bhìosaichean H-1B?
Chuir Deciphera Pharmaceuticals, LLC 7 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 26 Màrt 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Senior Manager, Analytical Development and Quality Control | 2 | $155,000 |
| Manager, Regulatory CMC | 1 | $135,000 |
| Sr. Scientist, Translational Medicine | 1 | $115,000 |
| Senior Manager, Clinical Science | 1 | $187,367 |
| Director, Regulatory Affairs | 1 | $220,000 |
| Senior Manager, Regulatory CMC | 1 | $158,484 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 2 | $145,000 |
| FY2025 | 3 | $187,367 |
| FY2026 | 2 | $156,742 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Regulatory Affairs Managers3
- Industrial Production Managers2
- Molecular and Cellular Biologists1
- Medical Scientists, Except Epidemiologists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Manager, Regulatory CMC | $158,484–$175,000 | Waltham, MA | 26 Màrt 2026 | 19 Ògmh 2026 | Dearbhaichte |
| Senior Manager, Analytical Development and Quality Control | $155,000–$180,000 Ìre III | North Grafton, MA | 26 Sult 2025 | 28 Samh 2025 | Dearbhaichte |
| Senior Manager, Clinical Science | $187,367 Ìre III | Cary, NC | 9 Cèit 2025 | 18 Iuch 2025 | Dearbhaichte |
| Sr. Scientist, Translational Medicine | $115,000–$150,000 Ìre III | Waltham, MA | 9 Cèit 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Director, Regulatory Affairs | $220,000–$263,000 Ìre III | Bloomfield, NJ | 23 Gibl 2025 | 12 Sult 2025 | Dearbhaichte |
| Manager, Regulatory CMC | $135,000–$145,000 | Waltham, MA | 16 Cèit 2023 | 19 Ògmh 2023 | Dearbhaichte |
| Senior Manager, Analytical Development and Quality Control | $155,000–$165,000 Ìre III | North Grafton, MA | 25 Dàmh 2022 | 28 Samh 2022 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).